Vesicular glutamate transporter VGLUT2 expression levels control quantal size and neuropathic pain

Journal of Neuroscience

Volumn 26, Issue 46, 2006, Pages 12055-12066

  Moechars, Diederik ^a   Weston, Matthew C ^b   Leo, Sandra ^a,c   Callaerts Vegh, Zsuzsanna ^c   Goris, Ilse ^a   Daneels, Guy ^a   Buist, A ^a   Cik, M ^a   Van Der Spek, P ^d   Kass, Stefan ^a   Meert, Theo ^a,c   D'Hooge, Rudi ^c   Rosenmund, Christian ^b   Hampson, R Mark ^a  

^a JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Chronic pain; Glutamate; Neurotransmitter transporter; Quantal size; Synaptic vesicles; Thalamus

Indexed keywords

VESICULAR GLUTAMATE TRANSPORTER 2;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; BRAIN NERVE CELL; CONTROLLED STUDY; ELECTROPHYSIOLOGY; FEMALE; GENE DISRUPTION; HIPPOCAMPUS; LEARNING; MALE; MEMORY; MOTOR PERFORMANCE; MOUSE; NEUROPATHIC PAIN; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TASTE AVERSION;

ANIMALS; CELLS, CULTURED; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; EXCITATORY POSTSYNAPTIC POTENTIALS; GENES, LETHAL; GLUTAMIC ACID; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURALGIA; PAIN MEASUREMENT; PERIPHERAL NERVOUS SYSTEM DISEASES; PRESYNAPTIC TERMINALS; SYNAPTIC TRANSMISSION; SYNAPTIC VESICLES; THALAMUS; VESICULAR GLUTAMATE TRANSPORT PROTEIN 2;

EID: 33751072363     PISSN: 02706474     EISSN: 02706474     Source Type: Journal    
DOI: 10.1523/JNEUROSCI.2556-06.2006     Document Type: Article

References (69)

1. +-dependent inorganic phosphate co transporter. J Neurochem 74:2622-2625.
2. Alexinsky T, Delacour J, Libouban S (1971) Thalamus and defensive conditioning: relative importance of the three medial structures. Physiol Behav 6:439-446.
3. Alvarez FJ, Villalba RM, Zerda R, Schneider SP (2004) Vesicular glutamate transporters in the spinal cord, with special reference to sensory primary afferent synapses. J Comp Neurol 472:257-280.
4. Bai L, Xu H, Collins JF, Ghishan FK (2001) Molecular and functional analysis of a novel neuronal vesicular glutamate transporter. J Biol Chem 276:36764-36769.
5. Bellocchio EE, Reimer RJ, Fremeau Jr RT, Edwards RH (2000) Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter. Science 289:957-960.
6. Bhatnagar S, Huber R, Lazar E, Pych L, Vining C (2003) Chronic stress alters behavior in the conditioned defensive burying test: role of the posterior paraventricular thalamus. Pharmacol Biochem Behav 76:343-349.
7. Bordi F, Quartaroli M (2000) Modulation of nociceptive transmission by NMDA/glycine site receptor in the ventroposterolateral nucleus of the thalamus. Pain 84:213-224.
8. Boulland JL, Qureshi T, Seal RP, Rafiki A, Gundersen V, Bergersen LH, Fremeau Jr RT, Edwards RH, Storm-Mathisen J, Chaudhry FA (2004) Expression of the vesicular glutamate transporters during development indicates the widespread corelease of multiple neurotransmitters. J Comp Neurol 480:264-280.
9. Bridges D, Thompson S, Rice R (2001) Mechanisms of neuropathic pain. Br J Anaesth 87:12-26.
10. Bruggemann J, Galhardo V, Apkarian AV (2001) Immediate reorganization of the rat somatosensory thalamus after partial ligation of sciatic nerve. J Pain 2:220-228.
11. Chiechio S, Copani A, Melchiorri D, Canudas AM, Storto M, Calvani M, Nicolai R, Nicoletti F (2004) Metabotropic receptors as targets for drugs of potential use in the treatment of neuropathic pain. J Endocrinol Invest 27:171-176.
12. Collins SD, Chessell IP (2005) Emerging therapies for neuropathic pain. Expert Opin Emerg Drugs 10:95-108.
13. Daniels RW, Collins CA, Gelfand MV, Dant J, Brooks ES, Krantz DE, DiAntonio A (2004) Increased expression of the Drosophila vesicular glutamate transporter leads to excess glutamate release and a compensatory decrease in quantal content. J Neurosci 24:10466-10474.
14. Daniels RW, Collins CA, Chen K, Gelfand MV, Featherstone DE, DiAntonio A (2006) A single vesicular glutamate transporter is sufficient to fill a synaptic vesicle. Neuron 49:11-16.
15. De Boer SF, Koolhaas JM (2003) Defensive burying in rodents: ethology, neurobiology and psychopharmacology. Eur J Pharmacol 463:145-161.
16. Decosterd I, Woolf CJ (2000) Spared nerve injury: an animal model of persistent peripheral neuropathic pain. Pain 87:149-158.
17. De Gois S, Schafer MK, Defamie N, Chen C, Ricci A, Weihe E, Varoqui H, Erickson JD (2005) Homeostatic scaling of vesicular glutamate and GABA transporter expression in rat neocortical circuits. J Neurosci 25:7121-7133.
18. D'Hooge R, Lullmann-Rauch R, Beckers T, Balschun D, Schwake M, Reiss K, von Figura K, Saftig P (2005) Neurocognitive and psychotiform behavioral alterations and enhanced hippocampal long-term potentiation in transgenic mice displaying neuropathological features of human alphamannosidosis. J Neurosci 25:6539-6549.
19. Dougherty PM, Li YJ, Lenz FA, Rowland L, Mittman S (1996) Evidence that excitatory amino acids mediate afferent input to the primate somatosensory thalamus. Brain Res 728:267-273.
20. Eastwood SL, Harrison PJ (2005) Decreased expression of vesicular glutamate transporter 1 and complexin II mRNAs in schizophrenia: further evidence for a synaptic pathology affecting glutamate neurons. Schizophr Res 73:159-172.
21. Fremeau Jr RT, Troyer MD, Pahner I, Nygaard GO, Tran CH, Reimer RJ, Bellocchio EE, Fortin D, Storm-Mathisen J, Edwards RH (2001) The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31:247-260.
22. Fremeau Jr RT, Voglmaier S, Seal RP, Edwards RH (2004a) VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci 27:98-103.
23. Fremeau Jr RT, Kam K, Qureshi T, Johnson J, Copenhagen DR, Storm-Mathisen J, Chaudhry FA, Nicoll RA, Edwards RH (2004b) Vesicular glutamate transporters 1 and 2 target to functionally distinct synaptic release sites. Science 304:1815-1819.
24. Fujiyama F, Furuta T, Kaneko T (2001) Immunocytochemical localization of candidates for vesicular glutamate transporters in the rat cerebral cortex. J Comp Neurol 435:379-387.
25. Gras C, Herzog E, Bellenchi GC, Bernard V, Ravassard P, Pohl M, Gasnier B, Giros B, El Mestikawy S (2002) A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J Neurosci 22:5442-5451.
26. Guilbaud G, Benoist JM, Jazat F, Gautron M (1990) Neuronal responsiveness in the ventrobasal thalamic complex of rats with an experimental peripheral mononeuropathy. J Neurophysiol 64:1537-1554.
27. Harris JA, Biersner RJ, Edwards D, Bailey LW (1975) Attention, learning, and personality during ketamine emergence: a pilot study. Anesth Analg 54:169-172.
28. Herzog E, Bellenchi GC, Gras C, Bernard V, Ravassard P, Bedet C, Gasnier B, Giros B, El Mestikawy S (2001) The existence of a second vesicular glutamate transporter specifies subpopulations of glutamatergic neurons. J Neurosci 21:RC181(1-6).
29. +-dependent inorganic phosphate cotransporter (DNPI) in the rat forebrain. Brain Res Mol Brain Res 83:34-43.
30. Ichimaru Y, Egawa T, Sawa A (1995) 5-HT1A-receptor subtype mediates the effect of fluvoxamine, a selective serotonin reuptake inhibitor, on marble-burying behavior in mice. Jpn J Pharmacol 68:65-70.
31. Kaneko T, Fujiyama F, Hioki H (2002) Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain. J Comp Neurol 444:39-62.
32. Kanki JP, Adams DB (1978) Ventrobasal thalamus necessary for visually-released defensive boxing of rat. Physiol Behav 21:7-12.
33. Kashani A, Betancur C, Giros B, Hirsch E, Mestikawy SE (2006) Altered expression of vesicular glutamate transporters VGLUT1 and VGLUT2 in Parkinson disease. Neurobiol Aging, in press.
34. Kolhekar R, Murphy S, Gebhart GF (1997) Thalamic NMDA receptors modulate inflammation-produced hyperalgesia in the rat. Pain 71:31-40.
35. Kidd B, Urban L (2001) Mechanisms of inflammatory pain. Br J Anaesth 87:3-11.
36. Kolb B, Whishaw IQ (1981) Neonatal frontal lesions in the rat: sparing of learned but not species-typical behavior in the presence of reduced brain weight and cortical thickness. J Comp Physiol Psychol 95:863-879.
37. Landry M, Bouali-Benazzouz R, El Mestikawy S, Ravassard P, Nagy F (2004) Expression of vesicular glutamate transporters in rat lumbar spinal cord, with a note on dorsal root ganglia. J Comp Neurol 468:380-394.
38. Lenz FA, Gracely RH, Hope EJ, Baker FH, Rowland LH, Dougherty PM, Richardson RT (1994) The sensation of angina can be evoked by stimulation of the human thalamus. Pain 59:119-125.
39. Lenz FA, Gracely RH, Romanoski AJ, Hope EJ, Rowland LH, Dougherty PM (1995) Stimulation in the human somatosensory thalamus can reproduce both the affective and sensory dimensions of previously experienced pain. Nat Med 1:910-913.
40. Li JL, Fujiyama F, Kaneko T, Mizuno N (2003) Expression of vesicular glutamate transporters, VGLUT1 and VGLUT2, in axon terminals of nociceptive primary afferent fibers in the superficial layers of the medullary and spinal dorsal horns of the rat. J Comp Neurol 457:236-249.
41. Maycox PR, Deckwerth T, Hell JW, Jahn R (1988) Glutamate uptake by brain synaptic vesicles. Energy dependence of transport and functional reconstitution in proteoliposomes. J Biol Chem 263:15423-15428.
42. Millan MJ, Lejeune F, Gobert A, Brocco M, Auclair A, Bosc C, Rivet JM, Lacoste JM, Cordi A, Dekeyne A (2000) S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors. II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. J Pharmacol Exp Ther 295:1206-1222.
43. Morris RG (1989) Synaptic plasticity and learning: selective impairment of learning rats and blockade of long-term potentiation in vivo by the N-methyl-D-aspartate receptor antagonist AP5. J Neurosci 9:3040-3057.
44. Neugebauer V (2002) Metabotropic glutamate receptors-important modulators of nociception and pain behavior. Pain 98:1-8.
45. +-dependent inorganic phosphate cotransporter. Proc Natl Acad Sci USA 91:5607-5611.
46. Njung'e K, Handley SL (1991) Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38:63-67.
47. Paradee W, Melikian HE, Rasmussen DL, Kenneson A, Conn PJ, Warren ST (1999) Fragile X mouse: strain effects of knockout phenotype and evidence suggesting deficient amygdala function. Neuroscience 94:185-192.
48. Phelps EA, LeDoux JE (2005) Contributions of the amygdala to emotion processing: from animal models to human behavior. Neuron 48:175-187.
49. Pothos EN, Larsen KE, Krantz DE, Liu Y, Haycock JW, Setlik W, Gershon MD, Edwards RH, Sulzer D (2000) Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size. J Neurosci 20:7297-7306.
50. Rosenmund C, Stevens CF (1996) Definition of the readily releasable pool of vesicles at hippocampal synapses. Neuron 16:1197-1207.
51. Schafer MK, Varoqui H, Defamie N, Weihe E, Erickson JD (2002) Molecular cloning and functional identification of mouse vesicular glutamate transporter 3 and its expression in subsets of novel excitatory neurons. J Biol Chem 277:50734-50748.
52. Shields SD, Eckert III WA, Basbaum AL (2003) Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis. J Pain 4:465-470.
53. Shimazaki T, Iijima M, Chaki S (2004) Anxiolytic-like activity of MGS0039, a potent group II metabotropic glutamate receptor antagonist, in a marble-burying behavior test. Eur J Pharmacol 501:121-125.
54. Stornetta RL, Sevigny CP, Guyenet PG (2003a) Inspiratory augmenting bulbospinal neurons express both glutamatergic and enkephalinergic phenotypes. J Comp Neurol 455:113-124.
55. Stornetta RL, Rosin DL, Wang H, Sevigny CP, Weston MC, Guyenet PG (2003b) A group of glutamatergic interneurons expressing high levels of both neurokinin-1 receptors and somatostatin identifies the region of the pre-Botzinger complex. J Comp Neurol 455:499-512.
56. Takahashi N, Miner LL, Sora I, Ujike H, Revay RS, Kostic V, Jackson-Lewis V, Przedborski S, Uhl GR (1997) VMAT2 knockout mice: heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity. Proc Natl Acad Sci USA 94:9938-9943.
57. Takamori S, Rhee JS, Rosenmund C, Jahn R (2000) Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons. Nature 407:189-194.
58. Takamori S, Rhee JS, Rosenmund C, Jahn R (2001) Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2). J Neurosci 21:RC182(1-6).
59. Takamori S, Malherbe P, Broger C, Jahn R (2002) Molecular cloning and functional characterization of human vesicular glutamate transporter 3. EMBO Rep 3:798-803.
60. Taylor BK, Peterson MA, Basbaum AI (1995) Persistent cardiovascular and behavioral nociceptive responses to subcutaneous formalin require peripheral nerve input. J Neurosci 15:7575-7584.
61. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K (1992) The formalin test: an evaluation of the method. Pain 51:5-17.
62. Vertes RP (2006) Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience 142:1-20.
63. Wattler S, Kelly M, Nehls M (1999) Construction of gene targeting vectors from lambda KOS genomic libraries. Biotechniques 26:1150-1156, 1158, 1160.
64. Wei F, Wang GD, Kerchner GA, Kim SJ, Xu HM, Chen ZF, Zhuo M (2001) Genetic enhancement of inflammatory pain by forebrain NR2B overexpression. Nat Neurosci 4:164-169.
65. Weston MC, Stornetta RL, Guyenet PG (2004) Glutamatergic neuronal projections from the marginal layer of the rostral ventral medulla to the respiratory centers in rats. J Comp Neurol 473:73-85.
66. Wilson NR, Kang J, Hueske EV, Leung T, Varoqui H, Murnick JG, Erickson JD, Liu G (2005) Presynaptic regulation of quantal size by the vesicular glutamate transporter VGLUT1. J Neurosci 25:6221-6234.
67. Wojcik SM, Rhee JS, Herzog E, Sigler A, Jahn R, Takamori S, Brose N, Rosenmund C (2004) An essential role for vesicular glutamate transporter 1 (VGLUT1) in postnatal development and control of quantal size. Proc Natl Acad Sci USA 101:7158-7163.
68. Yamamoto T, Fujimoto Y, Shimura T, Sakai N (1995) Conditioned taste aversion in rats with excitotoxic brain lesions. Neurosci Res 22:31-49.
69. Zieglgansberger W, Berthele A, Tolle TR (2005) Understanding neuropathic pain. CNS Spectr 10:298-308.